Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
7.21
+0.33 (4.80%)
Nov 6, 2026, 4:00 PM EST - Market closed
Profound Medical Revenue
Profound Medical had revenue of $9.83M in the quarter ending September 30, 2026, with 85.86% growth. This brings the company's total for the last twelve months to $23.63M, up 133.56% year-over-year. In the year 2025, Profound Medical had annual revenue of $16.10M with 50.73% growth.
Revenue (ttm)
$23.63M
Revenue Growth
+133.56%
P/S Ratio
11.12
Revenue / Employee
$145,846
Employees
162
Market Cap
262.77M
Revenue by Geography
- United States of America (USA) 12.25M 76.1%
- Canada 3.08M 19.1%
- Germany 773.00K 4.8%
Fiscal year ended Dec 31, 2025 See the full Profound Medical breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16.10M | 5.42M | 50.73% |
| Dec 31, 2024 | 10.68M | 3.48M | 48.35% |
| Dec 31, 2023 | 7.20M | 518.00K | 7.75% |
| Dec 31, 2022 | 6.68M | -192.00K | -2.79% |
| Dec 31, 2021 | 6.87M | -431.00K | -5.90% |
| Dec 31, 2020 | 7.30M | 3.13M | 74.99% |
| Dec 31, 2019 | 4.17M | 2.26M | 117.58% |
| Dec 31, 2018 | 1.92M | -1.98M | -50.81% |
| Dec 31, 2017 | 3.90M | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Viemed Healthcare | 310.37M |
| Treace Medical Concepts | 205.31M |
| Neuronetics | 159.76M |
| InfuSystem Holdings | 144.44M |
| RxSight | 121.83M |
| Standard BioTools | 84.43M |
| Electromed | 73.78M |
| ClearPoint Neuro | 45.49M |
PROF News
- 22 hours ago - What Profound Medical (PROF) Said on Its Q3 Earnings Call - MarketBeat
- 1 day ago - Profound Medical (PROF) Q3 2026 Earnings Call Transcript - The Motley Fool
- 1 day ago - Profound Medical Corp. Announces Fall In Q3 Income - Nasdaq
- 1 day ago - Profound Medical (PROF) Reports Q3 Loss, Beats Revenue Estimates - Nasdaq
- 1 day ago - Profound Medical reports Q3 EPS (21c), consensus (19c) - TheFly
- 1 day ago - Profound Medical Earnings Call Transcript: Q3 2026 - Transcripts
- 1 day ago - Profound Medical Earnings release: Q3 2026 - Filings
- 1 day ago - Profound Medical Quarterly report: Q3 2026 - Filings